Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

被引:471
作者
Caro, J. Jaime [1 ,2 ]
Briggs, Andrew H. [3 ]
Siebert, Uwe [4 ,5 ,6 ,8 ]
Kuntz, Karen M. [7 ]
机构
[1] United BioSource Corp, Lexington, MA 02420 USA
[2] McGill Univ, Fac Med, Montreal, PQ, Canada
[3] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland
[4] UMIT Univ Hlth Sci Med Informat & Technol, Innsbruck, Austria
[5] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA
[8] Oncotyrol Ctr Personalized Canc Med, Innsbruck, Austria
关键词
best practices; guidelines; methods; modeling; HEALTH TECHNOLOGY-ASSESSMENT; ECONOMIC-EVALUATION; DECISION; UNCERTAINTY;
D O I
10.1016/j.jval.2012.06.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Models-mathematical frameworks that facilitate estimation of the consequences of health care decisions-have become essential tools for health technology assessment. Evolution of the methods since the first ISPOR Modeling Task Force reported in 2003 has led to a new Task Force, jointly convened with the Society for Medical Decision Making, and this series of seven articles presents the updated recommendations for best practices in conceptualizing models; implementing state-transition approaches, discrete event simulations, or dynamic transmission models; and dealing with uncertainty and validating and reporting models transparently. This overview article introduces the work of the Task Force, provides all the recommendations, and discusses some quandaries that require further elucidation. The audience for these articles includes those who build models, stakeholders who utilize their results, and, indeed, anyone concerned with the use of models to support decision making.
引用
收藏
页码:796 / 803
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 2006, Decision modelling for health economic evaluation
[2]   Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models: A Practical Guide [J].
Bilcke, Joke ;
Beutels, Philippe ;
Brisson, Marc ;
Jit, Mark .
MEDICAL DECISION MAKING, 2011, 31 (04) :675-692
[3]  
Borshchev A., SYSTEM DYNAMICS DISC
[4]   A taxonomy of model structures for economic evaluation of health technologies [J].
Brennan, Alan ;
Chick, Stephen E. ;
Davies, Ruth .
HEALTH ECONOMICS, 2006, 15 (12) :1295-1310
[5]   Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 [J].
Briggs, Andrew H. ;
Weinstein, Milton C. ;
Fenwick, Elisabeth A. L. ;
Karnon, Jonathan ;
Sculpher, Mark J. ;
Paltiel, A. David .
VALUE IN HEALTH, 2012, 15 (06) :835-842
[6]  
Buxton MJ, 1997, HEALTH ECON, V6, P217, DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO
[7]  
2-W
[8]   Pharmacoeconamic analyses using discrete event simulation [J].
Caro, JJ .
PHARMACOECONOMICS, 2005, 23 (04) :323-332
[9]  
Caro JJ, IS HLTH OUTCOMES RES
[10]   Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7 [J].
Eddy, David M. ;
Hollingworth, William ;
Caro, J. Jaime ;
Tsevat, Joel ;
McDonald, Kathryn M. ;
Wong, John B. .
VALUE IN HEALTH, 2012, 15 (06) :843-850